Indaptus Therapeutics, Inc. (INDP)Healthcare | Biotechnology | New York, United States | NasdaqCM
3.45 USD
+0.41
(13.487%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 3.46 +0.01 (0.290%) ⇧ (April 17, 2026, 7:36 p.m. EDT) Short-term: ★★★★☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:53 a.m. EDT
Short-term bullish momentum driven by payroll financing and leadership reset outweighs weak fundamentals; long-term hold is speculative given negative earnings and dilution risks. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.281003 |
| AutoARIMA | 0.287231 |
| AutoTheta | 0.289694 |
| AutoETS | 0.289970 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 47% |
| H-stat | 1.23 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 2.85 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 7,736,018 |
| Forward P/E | -2.48 |
| Beta | 0.99 |
| Website | https://indaptusrx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.735023 |
| Address1 | Three Columbus Circle |
| Address2 | 15th Floor |
| All Time High | 21,952.0 |
| All Time Low | 1.51 |
| Ask | 3.53 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 115,350 |
| Average Daily Volume3 Month | 50,332 |
| Average Volume | 50,332 |
| Average Volume10Days | 115,350 |
| Beta | 0.991 |
| Bid | 3.38 |
| Bid Size | 1 |
| Book Value | 1.45 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.45 |
| Current Ratio | 1.512 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.47 |
| Day Low | 2.86 |
| Display Name | Indaptus Therapeutics |
| Dividend Date | 1,604,016,000 |
| Earnings Timestamp End | 1,747,224,001 |
| Earnings Timestamp Start | 1,747,224,001 |
| Ebitda | -19,832,778 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.038 |
| Enterprise Value | -761,610 |
| Eps Forward | -1.39 |
| Eps Trailing Twelve Months | -21.58 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.91498 |
| Fifty Day Average Change | 1.53502 |
| Fifty Day Average Change Percent | 0.8015854 |
| Fifty Two Week Change Percent | -73.502304 |
| Fifty Two Week High | 19.908 |
| Fifty Two Week High Change | -16.458 |
| Fifty Two Week High Change Percent | -0.8267028 |
| Fifty Two Week Low | 1.51 |
| Fifty Two Week Low Change | 1.94 |
| Fifty Two Week Low Change Percent | 1.2847682 |
| Fifty Two Week Range | 1.51 - 19.908 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,438,695,000,000 |
| Float Shares | 1,179,126 |
| Forward Eps | -1.39 |
| Forward P E | -2.4820144 |
| Free Cashflow | -8,159,969 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 5 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.37168998 |
| Held Percent Institutions | 0.01846 |
| Implied Shares Outstanding | 2,242,324 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-08-04 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,750,982,400 |
| Last Split Factor | 1:28 |
| Long Business Summary | Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York. |
| Long Name | Indaptus Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 7,736,018 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_278220029 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -20,848,916 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 7,780,864 |
| Number Of Analyst Opinions | 1 |
| Open | 2.925 |
| Operating Cashflow | -14,823,256 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 646 427 2727 |
| Post Market Change | 0.00999999 |
| Post Market Change Percent | 0.2898548 |
| Post Market Price | 3.46 |
| Post Market Time | 1,776,469,016 |
| Previous Close | 3.04 |
| Price Hint | 4 |
| Price To Book | 2.3793104 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.381 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.41 |
| Regular Market Change Percent | 13.4868 |
| Regular Market Day High | 3.47 |
| Regular Market Day Low | 2.86 |
| Regular Market Day Range | 2.86 - 3.47 |
| Regular Market Open | 2.925 |
| Regular Market Previous Close | 3.04 |
| Regular Market Price | 3.45 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 94,610 |
| Return On Assets | -1.4891 |
| Return On Equity | -5.87586 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 2,242,324 |
| Shares Percent Shares Out | 0.0058999998 |
| Shares Short | 13,325 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 19,488 |
| Short Name | Indaptus Therapeutics, Inc. |
| Short Percent Of Float | 0.0211 |
| Short Ratio | 0.56 |
| Source Interval | 15 |
| State | NY |
| Symbol | INDP |
| Target High Price | 10.0 |
| Target Low Price | 10.0 |
| Target Mean Price | 10.0 |
| Target Median Price | 10.0 |
| Total Cash | 8,507,628 |
| Total Cash Per Share | 3.794 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -21.58 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.942795 |
| Two Hundred Day Average Change | -0.492795 |
| Two Hundred Day Average Change Percent | -0.12498621 |
| Type Disp | Equity |
| Volume | 94,610 |
| Website | https://indaptusrx.com |
| Zip | 10,019 |